RxSight (RXST) Stock Price

$7.78 2.5%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    8

  • Fundamental

    7

  • Technical

    2

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on RxSight, AI stock picks, stock alerts and much more.

Sign up

RXST AI Stock Analysis

AI stock analysis for RXST is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like RxSight (RXST) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

RxSight (RXST) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of RxSight (RXST), currently trading at $7.78, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About RXST

LSE

Similar Stocks

ALGN Align Technology
ALGN		 $129
36.6%
5
IRTC iRhythm Technologies
IRTC		 $140.2
0.1%
6
DXCM Dexcom
DXCM		 $80.77
9.3%
5
BRKR Bruker
BRKR		 $38.43
6%
5
TMCI Treace Medical Concepts
TMCI		 $5.37
3.1%
4

News

Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 – RXST

Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 – RXST
July 31, 2025. globenewswire.com
Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd

Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd
July 31, 2025. globenewswire.com
Investors in RxSight, Inc. Should Contact The Gross Law Firm Before September 22, 2025 to Discuss Your Rights - RXST

Investors in RxSight, Inc. Should Contact The Gross Law Firm Before September 22, 2025 to Discuss Your Rights - RXST
July 31, 2025. prnewswire.com
RXST LAWSUIT ALERT: The Gross Law Firm Notifies RxSight, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

RXST LAWSUIT ALERT: The Gross Law Firm Notifies RxSight, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
July 30, 2025. globenewswire.com

RXST Alternative Data

Web Traffic

RxSight receives an estimated 11079 monthly visitors to rxsight.com.

  • Web Traffic

    11079

  • Change from Previous Month

    74.9%

  • 3 Month Change

    18.5%

  • YoY Change

    18.5%

Twitter Followers

RxSight has 264 Twitter Followers on its main Twitter (also known as X) account, which is up by 6% over the last month.

  • Twitter Followers

    264

  • Daily Change

    0%

  • 1 Month Change

    6%

  • 3 Month Change

    9.5%

  • YoY Change

    9.5%

Facebook Engagement

RxSight has engaged 44 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    44

  • Daily Change

    0%

  • 1 Month Change

    82.7%

  • 3 Month Change

    20%

  • YoY Change

    20%

Instagram Followers

RxSight has 2,212 Instagram Followers on its main Instagram account, up by 2.4% over the last month.

  • Instagram Followers

    2212

  • Daily Change

    0%

  • 1 Month Change

    2.4%

  • 3 Month Change

    6.9%

  • YoY Change

    6.9%

Youtube Subscribers

RxSight has 839 subscribers on its main Youtube channel, up by 1.2% over the last month.

  • Youtube Subscribers

    839

  • Daily Change

    0.1%

  • 1 Month Change

    1.2%

  • 3 Month Change

    4.2%

  • YoY Change

    4.2%

LinkedIn Followers

22,364 are following RxSight on LinkedIn, up by 1% over the last month.

  • LinkedIn Followers

    22364

  • Daily Change

    0%

  • 1 Month Change

    1%

  • 3 Month Change

    3.1%

Job Postings

RxSight has an estimated 10 open job postings, which is down -33.3% over the last month.

  • Job Postings

    10

  • Daily Change

    0%

  • 1 Month Change

    33.3%

  • 3 Month Change

    0%

  • YoY Change

    0%

LinkedIn Employees

According to LinkedIn, RxSight has 377 employees, down by -1.3% over the last month.

  • LinkedIn Employees

    377

  • Daily Change

    0%

  • 1 Month Change

    1.3%

  • 3 Month Change

    3.1%

  • YoY Change

    3.1%

Reddit Mentions

RxSight has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at RxSight is 55 out of 100 (neutral).

  • Business Outlook

    55

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

News Mentions

RxSight was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

RXST Financials

RXST Key Metrics

  • Total Revenue

    $40.2M

  • Net Income

    -$5.9M

  • Earnings per Share

    -$0.15

  • Free cash flow

    -$5.1M

  • EBITDA

    -$5.4M

  • EBITDA Ratio

    -0.134232

  • Total Assets

    $318.6M

RXST 2-year Revenue & Income
RXST 2-year Free Cash Flow

RXST Technicals

RXST SMA
RXST RSI

FAQ

What's the current price of RxSight (RXST) Stock?
The price of an RxSight (RXST) share is $7.78.

What's the market cap of RxSight?
The current market cap of RxSight is 316.2M.

Should I buy or sell RXST?
Multiple alternative data signals suggest that RxSight stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.

Is RxSight a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in RxSight stock. The bullish indicators suggest that RxSight's growth prospects and market position may lead to a positive performance in the foreseeable future.

Is now a good time to buy RxSight (RXST) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying RxSight stock, given the bullish outlook.

What are some stocks similar to RxSight (RXST) that investors often compare it to?
RxSight (RXST) is often compared to similar stocks such as Align Technology, iRhythm Technologies, Dexcom, Bruker and Treace Medical Concepts.

What is the forecast for RxSight's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast RxSight's stock price to be around $8.35 in 2026. Starting from the current price of $7.78, this represents a 7.3% change in price, indicating a bullish outlook for the stock.

How to buy RxSight (RXST) Stock?
RxSight stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy RxSight shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.